Global Oral Erectile Dysfunction Therapeutic Market Growth (Status and Outlook) 2024-2030

September 2024 | 94 pages | ID: G688D5246088EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Oral Erectile Dysfunction Therapeutic market size was valued at US$ 942.1 million in 2023. With growing demand in downstream market, the Oral Erectile Dysfunction Therapeutic is forecast to a readjusted size of US$ 1437.6 million by 2030 with a CAGR of 6.2% during review period.

The research report highlights the growth potential of the global Oral Erectile Dysfunction Therapeutic market. Oral Erectile Dysfunction Therapeutic are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oral Erectile Dysfunction Therapeutic. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oral Erectile Dysfunction Therapeutic market.

Erectile dysfunction (ED) is the type of sexual dysfunction when a man cannot maintain a firm erection of the penis or coitus.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on Oral Erectile Dysfunction Therapeutic market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Oral Erectile Dysfunction Therapeutic market. It may include historical data, market segmentation by Type (e.g., Protein, Hormones), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oral Erectile Dysfunction Therapeutic market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Oral Erectile Dysfunction Therapeutic market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Oral Erectile Dysfunction Therapeutic industry. This include advancements in Oral Erectile Dysfunction Therapeutic technology, Oral Erectile Dysfunction Therapeutic new entrants, Oral Erectile Dysfunction Therapeutic new investment, and other innovations that are shaping the future of Oral Erectile Dysfunction Therapeutic.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oral Erectile Dysfunction Therapeutic market. It includes factors influencing customer ' purchasing decisions, preferences for Oral Erectile Dysfunction Therapeutic product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oral Erectile Dysfunction Therapeutic market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oral Erectile Dysfunction Therapeutic market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oral Erectile Dysfunction Therapeutic market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oral Erectile Dysfunction Therapeutic industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oral Erectile Dysfunction Therapeutic market.

Market Segmentation:

Oral Erectile Dysfunction Therapeutic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Protein
  • Hormones
  • Other
Segmentation by application
  • Age <20
  • Age 20-30
  • Age 31-40
  • Age 41-50
  • Age >50
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Eli Lilly
  • Pfizer
  • Bayer
  • Teva Pharma
  • S.K. Chemicals
  • Seoul Pharma
  • CSBIO.

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Erectile Dysfunction Therapeutic Market Size 2019-2030
  2.1.2 Oral Erectile Dysfunction Therapeutic Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oral Erectile Dysfunction Therapeutic Segment by Type
  2.2.1 Protein
  2.2.2 Hormones
  2.2.3 Other
2.3 Oral Erectile Dysfunction Therapeutic Market Size by Type
  2.3.1 Oral Erectile Dysfunction Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type (2019-2024)
2.4 Oral Erectile Dysfunction Therapeutic Segment by Application
  2.4.1 Age $$$20
  2.4.2 Age 20-30
  2.4.3 Age 31-40
  2.4.4 Age 41-50
  2.4.5 Age $$$$50
2.5 Oral Erectile Dysfunction Therapeutic Market Size by Application
  2.5.1 Oral Erectile Dysfunction Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application (2019-2024)

3 ORAL ERECTILE DYSFUNCTION THERAPEUTIC MARKET SIZE BY PLAYER

3.1 Oral Erectile Dysfunction Therapeutic Market Size Market Share by Players
  3.1.1 Global Oral Erectile Dysfunction Therapeutic Revenue by Players (2019-2024)
  3.1.2 Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Oral Erectile Dysfunction Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL ERECTILE DYSFUNCTION THERAPEUTIC BY REGIONS

4.1 Oral Erectile Dysfunction Therapeutic Market Size by Regions (2019-2024)
4.2 Americas Oral Erectile Dysfunction Therapeutic Market Size Growth (2019-2024)
4.3 APAC Oral Erectile Dysfunction Therapeutic Market Size Growth (2019-2024)
4.4 Europe Oral Erectile Dysfunction Therapeutic Market Size Growth (2019-2024)
4.5 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Oral Erectile Dysfunction Therapeutic Market Size by Country (2019-2024)
5.2 Americas Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024)
5.3 Americas Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Erectile Dysfunction Therapeutic Market Size by Region (2019-2024)
6.2 APAC Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024)
6.3 APAC Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral Erectile Dysfunction Therapeutic by Country (2019-2024)
7.2 Europe Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024)
7.3 Europe Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Erectile Dysfunction Therapeutic by Region (2019-2024)
8.2 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024)
8.3 Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL ERECTILE DYSFUNCTION THERAPEUTIC MARKET FORECAST

10.1 Global Oral Erectile Dysfunction Therapeutic Forecast by Regions (2025-2030)
  10.1.1 Global Oral Erectile Dysfunction Therapeutic Forecast by Regions (2025-2030)
  10.1.2 Americas Oral Erectile Dysfunction Therapeutic Forecast
  10.1.3 APAC Oral Erectile Dysfunction Therapeutic Forecast
  10.1.4 Europe Oral Erectile Dysfunction Therapeutic Forecast
  10.1.5 Middle East & Africa Oral Erectile Dysfunction Therapeutic Forecast
10.2 Americas Oral Erectile Dysfunction Therapeutic Forecast by Country (2025-2030)
  10.2.1 United States Oral Erectile Dysfunction Therapeutic Market Forecast
  10.2.2 Canada Oral Erectile Dysfunction Therapeutic Market Forecast
  10.2.3 Mexico Oral Erectile Dysfunction Therapeutic Market Forecast
  10.2.4 Brazil Oral Erectile Dysfunction Therapeutic Market Forecast
10.3 APAC Oral Erectile Dysfunction Therapeutic Forecast by Region (2025-2030)
  10.3.1 China Oral Erectile Dysfunction Therapeutic Market Forecast
  10.3.2 Japan Oral Erectile Dysfunction Therapeutic Market Forecast
  10.3.3 Korea Oral Erectile Dysfunction Therapeutic Market Forecast
  10.3.4 Southeast Asia Oral Erectile Dysfunction Therapeutic Market Forecast
  10.3.5 India Oral Erectile Dysfunction Therapeutic Market Forecast
  10.3.6 Australia Oral Erectile Dysfunction Therapeutic Market Forecast
10.4 Europe Oral Erectile Dysfunction Therapeutic Forecast by Country (2025-2030)
  10.4.1 Germany Oral Erectile Dysfunction Therapeutic Market Forecast
  10.4.2 France Oral Erectile Dysfunction Therapeutic Market Forecast
  10.4.3 UK Oral Erectile Dysfunction Therapeutic Market Forecast
  10.4.4 Italy Oral Erectile Dysfunction Therapeutic Market Forecast
  10.4.5 Russia Oral Erectile Dysfunction Therapeutic Market Forecast
10.5 Middle East & Africa Oral Erectile Dysfunction Therapeutic Forecast by Region (2025-2030)
  10.5.1 Egypt Oral Erectile Dysfunction Therapeutic Market Forecast
  10.5.2 South Africa Oral Erectile Dysfunction Therapeutic Market Forecast
  10.5.3 Israel Oral Erectile Dysfunction Therapeutic Market Forecast
  10.5.4 Turkey Oral Erectile Dysfunction Therapeutic Market Forecast
  10.5.5 GCC Countries Oral Erectile Dysfunction Therapeutic Market Forecast
10.6 Global Oral Erectile Dysfunction Therapeutic Forecast by Type (2025-2030)
10.7 Global Oral Erectile Dysfunction Therapeutic Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly
  11.1.1 Eli Lilly Company Information
  11.1.2 Eli Lilly Oral Erectile Dysfunction Therapeutic Product Offered
  11.1.3 Eli Lilly Oral Erectile Dysfunction Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Eli Lilly Main Business Overview
  11.1.5 Eli Lilly Latest Developments
11.2 Pfizer
  11.2.1 Pfizer Company Information
  11.2.2 Pfizer Oral Erectile Dysfunction Therapeutic Product Offered
  11.2.3 Pfizer Oral Erectile Dysfunction Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Pfizer Main Business Overview
  11.2.5 Pfizer Latest Developments
11.3 Bayer
  11.3.1 Bayer Company Information
  11.3.2 Bayer Oral Erectile Dysfunction Therapeutic Product Offered
  11.3.3 Bayer Oral Erectile Dysfunction Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Bayer Main Business Overview
  11.3.5 Bayer Latest Developments
11.4 Teva Pharma
  11.4.1 Teva Pharma Company Information
  11.4.2 Teva Pharma Oral Erectile Dysfunction Therapeutic Product Offered
  11.4.3 Teva Pharma Oral Erectile Dysfunction Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Teva Pharma Main Business Overview
  11.4.5 Teva Pharma Latest Developments
11.5 S.K. Chemicals
  11.5.1 S.K. Chemicals Company Information
  11.5.2 S.K. Chemicals Oral Erectile Dysfunction Therapeutic Product Offered
  11.5.3 S.K. Chemicals Oral Erectile Dysfunction Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 S.K. Chemicals Main Business Overview
  11.5.5 S.K. Chemicals Latest Developments
11.6 Seoul Pharma
  11.6.1 Seoul Pharma Company Information
  11.6.2 Seoul Pharma Oral Erectile Dysfunction Therapeutic Product Offered
  11.6.3 Seoul Pharma Oral Erectile Dysfunction Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Seoul Pharma Main Business Overview
  11.6.5 Seoul Pharma Latest Developments
11.7 CSBIO.
  11.7.1 CSBIO. Company Information
  11.7.2 CSBIO. Oral Erectile Dysfunction Therapeutic Product Offered
  11.7.3 CSBIO. Oral Erectile Dysfunction Therapeutic Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 CSBIO. Main Business Overview
  11.7.5 CSBIO. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Oral Erectile Dysfunction Therapeutic Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Protein
Table 3. Major Players of Hormones
Table 4. Major Players of Other
Table 5. Oral Erectile Dysfunction Therapeutic Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type (2019-2024)
Table 8. Oral Erectile Dysfunction Therapeutic Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application (2019-2024)
Table 11. Global Oral Erectile Dysfunction Therapeutic Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Player (2019-2024)
Table 13. Oral Erectile Dysfunction Therapeutic Key Players Head office and Products Offered
Table 14. Oral Erectile Dysfunction Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Oral Erectile Dysfunction Therapeutic Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share by Regions (2019-2024)
Table 19. Global Oral Erectile Dysfunction Therapeutic Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas Oral Erectile Dysfunction Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas Oral Erectile Dysfunction Therapeutic Market Size Market Share by Country (2019-2024)
Table 23. Americas Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type (2019-2024)
Table 25. Americas Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application (2019-2024)
Table 27. APAC Oral Erectile Dysfunction Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC Oral Erectile Dysfunction Therapeutic Market Size Market Share by Region (2019-2024)
Table 29. APAC Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type (2019-2024)
Table 31. APAC Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application (2019-2024)
Table 33. Europe Oral Erectile Dysfunction Therapeutic Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe Oral Erectile Dysfunction Therapeutic Market Size Market Share by Country (2019-2024)
Table 35. Europe Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type (2019-2024)
Table 37. Europe Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of Oral Erectile Dysfunction Therapeutic
Table 46. Key Market Challenges & Risks of Oral Erectile Dysfunction Therapeutic
Table 47. Key Industry Trends of Oral Erectile Dysfunction Therapeutic
Table 48. Global Oral Erectile Dysfunction Therapeutic Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global Oral Erectile Dysfunction Therapeutic Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global Oral Erectile Dysfunction Therapeutic Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Eli Lilly Details, Company Type, Oral Erectile Dysfunction Therapeutic Area Served and Its Competitors
Table 53. Eli Lilly Oral Erectile Dysfunction Therapeutic Product Offered
Table 54. Eli Lilly Oral Erectile Dysfunction Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Eli Lilly Main Business
Table 56. Eli Lilly Latest Developments
Table 57. Pfizer Details, Company Type, Oral Erectile Dysfunction Therapeutic Area Served and Its Competitors
Table 58. Pfizer Oral Erectile Dysfunction Therapeutic Product Offered
Table 59. Pfizer Main Business
Table 60. Pfizer Oral Erectile Dysfunction Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. Pfizer Latest Developments
Table 62. Bayer Details, Company Type, Oral Erectile Dysfunction Therapeutic Area Served and Its Competitors
Table 63. Bayer Oral Erectile Dysfunction Therapeutic Product Offered
Table 64. Bayer Main Business
Table 65. Bayer Oral Erectile Dysfunction Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Bayer Latest Developments
Table 67. Teva Pharma Details, Company Type, Oral Erectile Dysfunction Therapeutic Area Served and Its Competitors
Table 68. Teva Pharma Oral Erectile Dysfunction Therapeutic Product Offered
Table 69. Teva Pharma Main Business
Table 70. Teva Pharma Oral Erectile Dysfunction Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Teva Pharma Latest Developments
Table 72. S.K. Chemicals Details, Company Type, Oral Erectile Dysfunction Therapeutic Area Served and Its Competitors
Table 73. S.K. Chemicals Oral Erectile Dysfunction Therapeutic Product Offered
Table 74. S.K. Chemicals Main Business
Table 75. S.K. Chemicals Oral Erectile Dysfunction Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. S.K. Chemicals Latest Developments
Table 77. Seoul Pharma Details, Company Type, Oral Erectile Dysfunction Therapeutic Area Served and Its Competitors
Table 78. Seoul Pharma Oral Erectile Dysfunction Therapeutic Product Offered
Table 79. Seoul Pharma Main Business
Table 80. Seoul Pharma Oral Erectile Dysfunction Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. Seoul Pharma Latest Developments
Table 82. CSBIO. Details, Company Type, Oral Erectile Dysfunction Therapeutic Area Served and Its Competitors
Table 83. CSBIO. Oral Erectile Dysfunction Therapeutic Product Offered
Table 84. CSBIO. Main Business
Table 85. CSBIO. Oral Erectile Dysfunction Therapeutic Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. CSBIO. Latest Developments

LIST OF FIGURES

Figure 1. Oral Erectile Dysfunction Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Erectile Dysfunction Therapeutic Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oral Erectile Dysfunction Therapeutic Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oral Erectile Dysfunction Therapeutic Sales Market Share by Country/Region (2023)
Figure 8. Oral Erectile Dysfunction Therapeutic Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type in 2023
Figure 10. Oral Erectile Dysfunction Therapeutic in Age <20
Figure 11. Global Oral Erectile Dysfunction Therapeutic Market: Age <20 (2019-2024) & ($ Millions)
Figure 12. Oral Erectile Dysfunction Therapeutic in Age 20-30
Figure 13. Global Oral Erectile Dysfunction Therapeutic Market: Age 20-30 (2019-2024) & ($ Millions)
Figure 14. Oral Erectile Dysfunction Therapeutic in Age 31-40
Figure 15. Global Oral Erectile Dysfunction Therapeutic Market: Age 31-40 (2019-2024) & ($ Millions)
Figure 16. Oral Erectile Dysfunction Therapeutic in Age 41-50
Figure 17. Global Oral Erectile Dysfunction Therapeutic Market: Age 41-50 (2019-2024) & ($ Millions)
Figure 18. Oral Erectile Dysfunction Therapeutic in Age >50
Figure 19. Global Oral Erectile Dysfunction Therapeutic Market: Age >50 (2019-2024) & ($ Millions)
Figure 20. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application in 2023
Figure 21. Global Oral Erectile Dysfunction Therapeutic Revenue Market Share by Player in 2023
Figure 22. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Oral Erectile Dysfunction Therapeutic Market Size 2019-2024 ($ Millions)
Figure 24. APAC Oral Erectile Dysfunction Therapeutic Market Size 2019-2024 ($ Millions)
Figure 25. Europe Oral Erectile Dysfunction Therapeutic Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size 2019-2024 ($ Millions)
Figure 27. Americas Oral Erectile Dysfunction Therapeutic Value Market Share by Country in 2023
Figure 28. United States Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Oral Erectile Dysfunction Therapeutic Market Size Market Share by Region in 2023
Figure 33. APAC Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type in 2023
Figure 34. APAC Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application in 2023
Figure 35. China Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Oral Erectile Dysfunction Therapeutic Market Size Market Share by Country in 2023
Figure 42. Europe Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type (2019-2024)
Figure 43. Europe Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application (2019-2024)
Figure 44. Germany Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Oral Erectile Dysfunction Therapeutic Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 58. APAC Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 59. Europe Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 61. United States Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 62. Canada Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 65. China Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 66. Japan Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 67. Korea Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 69. India Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 70. Australia Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 71. Germany Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 72. France Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 73. UK Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 74. Italy Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 75. Russia Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 76. Spain Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 79. Israel Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Oral Erectile Dysfunction Therapeutic Market Size 2025-2030 ($ Millions)
Figure 82. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Oral Erectile Dysfunction Therapeutic Market Size Market Share Forecast by Application (2025-2030)